Runx2, p53, and pRB Status as Diagnostic Parameters for Deregulation of Osteoblast Growth and Differentiation in a New Pre-Chemotherapeutic Osteosarcoma Cell Line (OS1)

B.P. Pereira, Y.F. Zhou, A. Gupta, D.T. Leong, K.Z. Aung, L. Ling, R.W.H. Pho, M. Galindo, Manuel Salto-Tellez, G.S. Stein, S.M. Cool, A.J. Van Wijnen, S.S. Nathan

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Abstract

Osteosarcomas are the most prevalent primary bone tumors found in pediatric patients. To understand their molecular etiology, cell culture models are used to define disease mechanisms under controlled conditions. Many osteosarcoma cell lines (e.g., SAOS-2, U2OS, MG63) are derived from Caucasian patients. However, patients exhibit individual and ethnic differences in their responsiveness to irradiation and chemotherapy. This motivated the establishment of osteosarcoma cell lines (OS1, OS2, OS3) from three ethnically Chinese patients. OS1 cells, derived from a pre-chemotherapeutic tumor in the femur of a 6-year-old female, were examined for molecular markers characteristic for osteoblasts, stem cells, and cell cycle control by immunohistochemistry, reverse transcriptase-PCR, Western blotting and flow cytometry. OS I have aberrant G-banded karyotypes, possibly reflecting chromosomal abnormalities related to p53 deficiency. OS I had ossification profiles similar to human fetal osteoblasts rather than SAOS-2 which ossifies ab initio, (P
Original languageEnglish
Pages (from-to)778-788
Number of pages11
JournalJournal of Cellular Physiology
Volume221
Issue number3
DOIs
Publication statusPublished - Dec 2009

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Physiology

Fingerprint

Dive into the research topics of 'Runx2, p53, and pRB Status as Diagnostic Parameters for Deregulation of Osteoblast Growth and Differentiation in a New Pre-Chemotherapeutic Osteosarcoma Cell Line (OS1)'. Together they form a unique fingerprint.

Cite this